Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingjie Fan

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Clinical and Translational Medicine|May 13, 2024
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trialXiaochu Man, Jie Huang, Shujuan Sun, et al.
JAMA Network Open|May 18, 2019
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung CancerHaiyan Zeng, Rui Li, Chen Hu, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Clinical and Translational Medicine|May 13, 2024
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trialXiaochu Man, Jie Huang, Shujuan Sun, et al.
JAMA Network Open|May 18, 2019
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung CancerHaiyan Zeng, Rui Li, Chen Hu, et al.
Pageof 6